Posted by on Apr 10, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This phase 3 trial aims to test the safety and effectiveness of a combined treatment with brentuximab vedotin (BV; Adcetris) and combination chemotherapy in younger patients with recently diagnosed Hodgkin lymphoma. The main outcome to be measured will be the side effects related to treatment and the response of the tumor to the...

Read More